COSM Valuation

Cosmos Health Inc

Add to Watchlist

Advanced Chart

0.907

+0.012(1.340%)1D

Overview
Forecast
Valuation
Earnings

COSM Relative Valuation

COSM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, COSM is overvalued; if below, it's undervalued.

Historical Valuation

Cosmos Health Inc (COSM) is now in the Overvalued zone, suggesting that its current forward PS ratio of 0.37 is considered Overvalued compared with the five-year average of 1.86. The fair price of Cosmos Health Inc (COSM) is between 0.32 to 0.61 according to relative valuation methord. Compared to the current price of 0.91 USD , Cosmos Health Inc is Overvalued By 48.72%.

Relative Value

Fair Zone

0.32-0.61

Current Price：0.91

48.72%

Overvalued

89.53

Trailing

Forward

10.73

EV/EBITDA

Cosmos Health Inc. (COSM) has a current EV/EBITDA of 10.73. The 5-year average EV/EBITDA is -2.38. The thresholds are as follows: Strongly Undervalued below -19.77, Undervalued between -19.77 and -11.07, Fairly Valued between 6.31 and -11.07, Overvalued between 6.31 and 15.00, and Strongly Overvalued above 15.00. The current Forward EV/EBITDA of 10.73 falls within the Overvalued range.

66.86

EV/EBIT

Cosmos Health Inc. (COSM) has a current EV/EBIT of 66.86. The 5-year average EV/EBIT is 1.07. The thresholds are as follows: Strongly Undervalued below -24.91, Undervalued between -24.91 and -11.92, Fairly Valued between 14.06 and -11.92, Overvalued between 14.06 and 27.05, and Strongly Overvalued above 27.05. The current Forward EV/EBIT of 66.86 falls within the Strongly Overvalued range.

0.37

Cosmos Health Inc. (COSM) has a current PS of 0.37. The 5-year average PS is 0.19. The thresholds are as follows: Strongly Undervalued below -0.31, Undervalued between -0.31 and -0.06, Fairly Valued between 0.44 and -0.06, Overvalued between 0.44 and 0.69, and Strongly Overvalued above 0.69. The current Forward PS of 0.37 falls within the Historic Trend Line -Fairly Valued range.

13.95

P/OCF

Cosmos Health Inc. (COSM) has a current P/OCF of 13.95. The 5-year average P/OCF is -0.68. The thresholds are as follows: Strongly Undervalued below -17.54, Undervalued between -17.54 and -9.11, Fairly Valued between 7.75 and -9.11, Overvalued between 7.75 and 16.18, and Strongly Overvalued above 16.18. The current Forward P/OCF of 13.95 falls within the Overvalued range.

0.00

P/FCF

Cosmos Health Inc. (COSM) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.

Cosmos Health Inc (COSM) has a current Price-to-Book (P/B) ratio of 0.94. Compared to its 3-year average P/B ratio of 0.69 , the current P/B ratio is approximately 35.29% higher. Relative to its 5-year average P/B ratio of 9.36, the current P/B ratio is about -89.97% higher. Cosmos Health Inc (COSM) has a Forward Free Cash Flow (FCF) yield of approximately -19.08%. Compared to its 3-year average FCF yield of -83.32%, the current FCF yield is approximately -77.10% lower. Relative to its 5-year average FCF yield of -61.56% , the current FCF yield is about -69.00% lower.

0.94

P/B

Median3y

0.69

Median5y

9.36

-19.08

FCF Yield

Median3y

-83.32

Median5y

-61.56

Competitors Valuation Multiple

The average P/S ratio for COSM's competitors is 0.06, providing a benchmark for relative valuation. Cosmos Health Inc Corp (COSM) exhibits a P/S ratio of 0.37, which is 500.00% above the industry average. Given its robust revenue growth of -5.98%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Cuprina Holdings (Cayman) Ltd

Loss

25.53M

TENX.O

Tenax Therapeutics Inc

Rein Therapeutics Inc

Performance Decomposition

Market capitalization of COSM decreased by 23.15% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -0.66 to -0.90.

The secondary factor is the Revenue Growth, contributed -5.98%to the performance.

Overall, the performance of COSM in the past 1 year is driven by P/E Change. Which is more unsustainable.

-5.98%

14.58M → 13.71M

Revenue Growth

-53.36%

-12.80 → -5.97

Margin Expansion

36.19%

-0.66 → -0.90

P/E Change

-23.15%